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up in primary care 
versus secondary care: 
a qualitative study
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Objective To explore patients’ preferences for follow-up in primary care vs. 
secondary care.
Methods A cross-sectional design was employed, involving semi-struc-
tured interviews with 70 female patients with a history of early-stage 
breast cancer. Using descriptive content analysis, interview transcripts 
were analysed independently and thematically by two researchers.
Findings Patients expressed the strongest preference for annual visits 
(31/68), a schedule with a decreasing frequency over time (27/68), and 
follow-up  >10  years, including lifelong follow-up (20/64). The majority 
(56/61) preferred to receive follow-up care from the same care provider 
over time, for reasons related to a personal doctor-patient relationship 
and the physician’s knowledge of the patient’s history. About 75% (43/56) 
preferred specialist follow-up to other follow-up models. However, prima-
ry care-based follow-up would be accepted by 57% (39/68) provided that 
there is good communication between GPs and specialists, and sufficient 
knowledge among GPs about follow-up. Perceived benefits of primary 
care-based follow-up referred to the personal nature of the GP-patient 
relationship and the easy access to primary care. Perceived barriers in-
cluded limited oncology knowledge and skills, time available, motivation 
among GPs to provide follow-up care and patients’ confidence with the 
present specialist follow-up.
Conclusions More than half of the patients were open to primary care-
based follow-up. Patients’ confidence with this follow-up model may 
increase by using survivorship care plans to facilitate communication 
across the primary/secondary interface and with patients. Training GPs to 
improve their oncology knowledge and skills might also increase patients’ 
confidence.
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Breast cancer is the most common malignancy and the leading cause of 
cancer-related death in women worldwide, accounting for 23% of new 
cancer cases and 14% of cancer deaths in 2008.8 Survival of breast cancer 
patients has increased in many countries as a result of early detection 
through mammography and improved treatment.8 This will place an in-
creasing burden on follow-up oncology clinics129 and primary care, due to 
the demand for cancer surveillance after completion of primary treatment 
and general medical care for co-morbid conditions.60 This highlights the 
need for an effective resource allocation between primary care and hos-
pital care in the future, and possible transfer of follow-up to the general 
practitioner (GP).60
Transfer of breast cancer follow-up to the primary care setting has to 
be accepted by all parties involved, including the patients. In two cross-
sectional surveys,88,130 and a discrete choice experiment89 most patients 
with a history of breast cancer preferred specialist follow-up to GP-led 
follow-up. In two surveys, primary care-based follow-up was acceptable 
to 5-39% of the patients87,90 and to 55 and 67% of patients invited to par-
ticipate in two randomized clinical trials comparing hospital and primary 
care-based breast cancer follow-up.52,131 However, these studies used 
quantitative methods and were performed in a hospital setting.
Qualitative research can provide a deeper understanding of the accept-
ance of primary care-based follow-up by patients. To our knowledge, 
three qualitative studies have explored patients’ preferences concerning 
primary care-based follow-up. One study reported that Australian breast 
cancer survivors are willing to accept an increased role for their GP in a 
shared care model,132,133 while in another study US breast cancer survivors 
do not think that their primary care physician has a central role in their 
survivorship care.95 An earlier study found that UK patients prefer access 
to specialist services, particularly during the early stages of follow-up.91 
As health-care systems may differ between countries worldwide, more 
qualitative research concerning patients’ preferences in the issue of pri-
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mary care-based follow-up is needed. We conducted a qualitative study 
among Dutch patients recruited in general practice, in which the aim was 




A qualitative study was performed in the context of the Dutch healthcare 
system, in which primary care has played a central role for many years. 
Almost all citizens are registered with a GP, who deals with 95% of health 
problems presented by patients.115 At the time this study was conducted, 
the Dutch breast cancer guidelines recommended hospital follow-up for 
5 years, including annual mammography. Physical examination had to be 
performed every 3 months in the first year, every 6 months in the sec-
ond year and annually thereafter. After 5 years, annual follow-up visits 
and mammography appointments in the hospital were recommended for 
patients aged ≤60 years. Patients aged >60 years who had undergone 
mastectomy had to be referred to the national screening programme for 
biennial mammography. For patients aged >60 years, and treated with 
breast-conserving therapy, discharge to their GP for annual physical ex-
amination was recommended, combined with biennial mammographic 
follow-up in the hospital.44,59
A cross-sectional design was employed, involving semi-structured inter-
views with 70 female patients with a history of early-stage breast cancer 
recruited from GP offices of the Registration Network Groningen (RNG). 
This general practice research network was established in 1989 and con-
sists of three group practices with 17 GPs and a dynamic population of 
about 30 000 patients in the city of Groningen and the smaller towns 
Hoogeveen and Sappemeer in the northern part of the Netherlands.99 
To protect patient identity, reference numbers were assigned, and data 
were stored against these numbers. According to the Institutional Review 
Board of the University Medical Center Groningen (UMCG), no approval 
was needed as this non-invasive study was not subject to the Dutch Medi-
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cal Research Involving Human Subjects Act. The principal aim of this Act 
is to provide protection for human subjects who take part in medical re-
search.134,135
Recruitment of patients
Using the RNG database, we searched for patients who had a recorded 
code for female breast malignancy in their record between 1998 and 2007 
and who were also registered with a participating GP at the start of the 
study (1 January 2009). We identified 167 of such patients (Figure 1). Confir-
mation of breast cancer in history was obtained by going back to the par-
ticipating general practices; subsequently, additional information about 
breast cancer diagnosis, stages, treatments and recurrences was collect-
ed for these women.99 GPs from the RNG were asked to include patients 
with a history of breast cancer who were able to participate in the study. A 
total of 18 patients were excluded from the study for the reasons shown in 
Figure 1. Patients with distant metastasis at diagnosis or during follow-up 
were excluded because they are expected to use more (palliative) health 
care in general practice than patients treated with curative intent. Eligible 
patients (n=149) were sent a letter, an information leaflet about the study 
and an informed consent form by their own GP, to ensure that only pa-
tients who gave their written informed consent (n=72) were contacted and 
interviewed by the researchers. Two patients were excluded after inter-
viewing because of distant metastasis during follow-up, or missing data.
Interview guide development and data collection
Based on a literature review and interviews with three patients not linked 
to the RNG, a semi-structured interview guide was developed. The intro-
ductory part of this guide addressed patients’ experiences with diagno-
sis, treatment and follow-up to let patients ‘tell their story’ of the breast 
cancer experience. The first part focused on patients’ preferences for 
follow-up in primary care vs. secondary care; the second part focused on 
patients’ perceptions of the aims of follow-up. In this chapter, we report 
on patients’ preferences for follow-up. To test the interview guide, pilot 
interviews were held with 10 patients from the RNG. Themes related to 
care provider continuity emerged from these interviews and were added 
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to the interview guide. The final interview guide was used in the remaining 
62 interviews.
Most interviews were conducted by a final year medical student (CS, male), 
who had completed his clinical training and participated in the research 
project to finish his Master’s degree. He had passed the tests related to 
learning communication skills and clinical interviewing, as these are part 
of the medical school curriculum. One patient requested to be interviewed 
by a female researcher (CR). Patients were interviewed individually in their 
own home (n=69), in the general practice (n=2) or at our Department of 
General Practice (n=1). Each interview lasted 30-60 min, was audio-re-
corded and transcribed verbatim. Confidentiality of the interview data was 
discussed at the beginning of the interviews. Patients were assured that 
their data would be processed and analysed anonymously.
No relationship was established between the researchers and the pa-
tients prior to study commencement. Before being contacted, the patient 
did not know anything about the researchers, except for a name, occupa-
tion and the reason for conducting the interview. This information was 
provided in the letter, the information leaflet and the informed consent 
form. Furthermore, the researchers briefly introduced themselves at the 
beginning of each interview.
Data analysis
Descriptive statistics were used to describe patients’ characteristics. In-
terview data were coded by two researchers using descriptive content 
analysis.136 First, one researcher (MdF, female) organized transcribed text 
concerning patients’ preferences for follow-up into display tables, as de-
scribed by Miles and Huberman.137 Next, two researchers independently 
reviewed these tables and coded patients’ responses based upon the 
predetermined themes in the interview guide (Table 1). The researchers 
discussed any discrepancies in the findings until consensus was reached. 
Summaries were written and illustrated with quotes of patients. For the 
predetermined themes, the numbers of responses were counted. In this 
way, a cross-case approach with a variable-oriented strategy was used in 
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the data analysis.137,138 Data saturation was not determined as data analy-
sis took place after completion of data collection. However, after analys-
ing the majority of the interviews, no new themes appeared indicating 
saturation.
RESULTS
Characteristics of the included patients are presented in Table 2. Median 
age at the time of the interview was 62.6 years (range 34.5-88.4). Median 
time since breast cancer diagnosis was 7.0 years (range 1.0-23.1). No sig-
nificant differences were found between the characteristics of the includ-
ed patients (n=70) and the non-respondents/excluded patients (n=79) 
(data not shown).
Follow-up frequency
Patients expressed the strongest preference for annual visits (31/68) (Ta-
ble 3). Other frequently mentioned options included visits twice a year 
(10/68) and a schedule with a decreasing frequency over time (10/68). 
During the interviews, 27 patients said they would like a schedule with a 
decreasing frequency over time.
For all that fuss I think once a year is certainly enough; I don’t need to have 
that mammogram more often (P21, age 65 years).
Well, 3 months and then half a year, that scaling down, I like that. And then 
after 2 years, once every year. Yes, I think that’s good (P06, age 86 years).
Follow-up duration
The most preferred duration of follow-up was >10 years, including life-
long follow-up (20/64) (Table 3). Other frequently mentioned options were 
10 years of follow-up (16/64) and 5 years of follow-up (8/64).
The way I think about it now: maybe forever. Only it was 5 years ago… and 
after 10 years I might say, of course not. But that feeling, it does gives you 
a bit of security, if you’re checked at least once a year … So, as far as I’m 
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concerned I’d go for the expensive solution - let them go on controlling me 
for a long time… (P33, age 57 years).
Care provider continuity
The majority of patients (56/61) preferred to receive follow-up care from 
the same care provider at each visit. Most explanations for this prefer-
ence are related to a personal doctor-patient relationship (of trust) and 
the physicians’ knowledge of the patients’ history (so that patients do not 
have to present their story over and over again). Three patients consid-
ered a lack of care continuity as an advantage in terms of receiving differ-
ent opinions. Two others declared that they were neutral with respect to 
care provider continuity.
Great. You build up a sort of band. If it would be someone else every time, 
then I’d think: what have I got now. They do have something on paper, but 
still …. I wouldn’t like to keep having a different GP (P39, age 72 years).
Then Doctor X was sick, and then another doctor came who said: 4 years 
tamoxifen? Not 5 years? And then I had to explain that…. and then another 
doctor came and then something else was unclear … but because it was 
someone else every time, I found that very unpleasant (P67, age 34 years).
Follow-up care provider: first choice
During the interviews, patients were asked which care provider should 
provide their follow-up. About 75% (43/56) preferred specialist follow-up 
to other follow-up models, including GP-led follow-up (4/56), nurse-led 
follow-up (2/56) and follow-up alternately provided by specialist and/or 
GP and/or nurse (5/56). Two patients preferred to receive follow-up care 
from someone who can best provide this care.
Well, you could say the GP because he knows you the best. But yes, the 
surgeon really knows more about it …. So yes, then rather the surgeon 
(P30, age 48 years).
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Follow-up provided by the GP would be accepted by 57% of patients 
(39/68) (Table 4). One of these patients found this follow-up model ac-
ceptable after 5 years of hospital follow-up. Another commented that she 
would only accept follow-up provided by her own GP (and not by other 
GPs). None of the characteristics presented in Table 2 were significantly 
associated with patients’ willingness to accept GP-led follow-up (data not 
shown). Patients’ motives for accepting this follow-up model included 
having a relationship of trust with the GP, receiving more personal atten-
tion in general practice than in the hospital, and having less travelling/
waiting time as the general practice is nearby and easily accessible. How-
ever, good communication between GPs and specialists and sufficient 
knowledge among GPs about follow-up, were considered essential by the 
patients.
Well, I’d approve of that … As you get older, that’s much better for us. Be-
cause it’s close by and then you don’t have to go to the hospital and you 
don’t have that dreadful waiting room (P58, age 70 years).
I find that OK, as long as he discusses everything with the various doctors 
and he stays up to date. Because in general the GP is a bit less up to date 
about what’s really going on in terms of therapies (P10, age 36 years).
Follow-up provided by the GP would not be accepted by 41% (28/68) (Ta-
ble 4). One patient felt neutral with respect to GP led follow-up. Patients 
who found GP-led follow-up unacceptable were concerned about (lim-
ited) oncology education, knowledge and experience among GPs (Table 
4). Furthermore, they thought that GPs had too little time available and 
were not motivated to provide follow-up care. Patients expressed less 
confidence in their GP and more confidence in specialists with respect 
to breast cancer follow-up. Also, patients were satisfied with the present 
hospital follow-up. Other barriers to GP-led follow-up included GPs miss-
ing breast cancer diagnosis, GPs seen as referring agents to the hospital, 
no GP involvement during the active treatment phase, mammography ap-
pointments in the hospital and perceived effective links within the hospital. 
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I think - the more experienced your fingers are, the faster you can detect 
something … And a GP has just seen someone with a runny nose, and then 
I come in between with my breasts, because there’s also a man with a sore 
toe waiting. According to my feeling, it seems better to have someone do 
this - who’s doing this every single day (P44, age 61 years).
Care provider continuity: GP vs. specialists
When patients could choose between follow-up provided by their own 
GP vs. follow-up provided by different specialists (lack of care provider 
continuity), 55% of these patients (21/38) would choose the first option, 
while 34% (13/38) preferred the second option. In that case, two patients 
would terminate follow-up. One patient would go to another hospital for 
follow-up, while another patient stated she had no preference for either 
of the options.
Yes, then rather with the GP - that’s the contact that you still have. And 
also … the feeling that there’s attention for you at that moment, instead of 
being just a number on a letter, and someone just gives you the message 
(P62, age 55 years)
DISCUSSION
This qualitative study explored preferences for breast cancer follow-up in 
primary care vs. secondary care, among female patients with a history of 
early-stage breast cancer recruited in general practice. The women ex-
pressed the strongest preference for annual visits, a schedule with a de-
creasing frequency over time, and follow-up >10 years, including lifelong 
follow-up. The majority preferred to receive follow-up care from the same 
care provider over time, for reasons related to a personal doctor-patient 
relationship and the physicians’ knowledge of the patients’ history. About 
75% preferred specialist follow-up to other follow-up models. However, 
follow-up by the GP would be accepted by 57%, provided that there is 
good communication between GPs and specialists and sufficient knowl-
edge among GPs about follow-up. Perceived benefits of GP-led follow-
up referred to the personal nature of the GP-patient relationship and the 
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easy access to primary care. Perceived barriers to GP-led follow-up in-
cluded limited oncology knowledge and skills, time available, motivation 
among GPs to provide follow-up care and patients’ confidence with the 
present specialist follow-up.
In line with our results, others have also shown that patients with a history 
of breast cancer and participating in a hospital follow-up program strongly 
prefer visits once or twice a year (depending on time since treatment) and 
lifelong follow-up.88,90 Before entering hospital follow-up, most patients 
expect to go back to the clinic once or twice a year, but are uncertain as 
to how long they would remain in follow-up.139 As in our study, others also 
reported the importance of care provider continuity.87,91,92,132,133,140 Among 
Australian breast cancer survivors, the main reason for preferring to re-
ceive follow-up care from the same care provider over time was the doc-
tor-patient relationship developed during the active treatment phase.133
Our study supports earlier quantitative88,89,130 and qualitative95,132,133 find-
ings that patients with a history of breast cancer prefer specialist follow-
up to primary care-based follow-up. When interpreting these findings, 
it should be kept in mind that patients tend to prefer the most familiar 
situation.88,89 In our study, all patients were diagnosed with breast cancer 
before 2008; at that time, Dutch GPs did not play a formal role in breast 
cancer follow-up care. Other studies reported that patients who already 
received breast cancer follow-up or survivorship care from their primary 
care physician were satisfied with it53,93,141 and did not report any disadvan-
tage.132 Furthermore, patients’ preference for specialist follow-up seems 
to be related to a strong specialist-patient relationship developed during 
the active treatment phase.132,133 If follow-up is transferred to the primary 
care setting, formal involvement of GPs during the active treatment phase 
might increase patient’s confidence with primary care-based follow-up.
In the present study, despite patients’ preference for specialist follow-up, 
primary care-based follow-up was acceptable to 57% of patients, com-
pared to 5-39% of patients in two surveys87,90 and 55 and 67% of patients 
participating in two randomized clinical trials.52,131 Patients in our study, 
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similar to patients in an Australian qualitative study,132,133 considered the 
GP-patient relationship and the easy access to primary care as benefits 
of primary care-based follow-up. However, good communication between 
GPs and specialists and sufficient knowledge among GPs about follow-
up were regarded as prerequisites to accept this follow-up model. Breast 
cancer survivors in other countries found deficiencies in the communi-
cation between primary care and specialist care93,133 and felt that writ-
ten documentation or on-going communication between their specialists 
and primary care physicians would be helpful in coordinating their care.95 
Therefore, survivorship care plans may be useful instruments to facilitate 
communication among patients and health-care providers.30,31,125
Limited education, knowledge, experience, time and motivation among 
GPs were perceived barriers for the patients both in our study and in three 
previous qualitative studies91,95,132,133 to accept primary care-based follow-
up. Furthermore, in another qualitative study, the majority of women re-
ceiving hospital follow-up care (n=15) did not contact their GP because 
they considered them to be too busy or to be lacking in specialist knowl-
edge.92 Informing women of the educational activities of their GP might 
increase their confidence with primary care-based follow-up.132
Major strengths of this study are the large sample of participants (n=70) 
recruited in a community setting (general practice) and that the sample 
covers the preferences for follow-up of women (aged 34-88 years) with 
a history of breast cancer and living from 1 to 23 years after diagnosis. 
Trustworthiness of the findings was enhanced by the use of verbatim tran-
scripts and by using two researchers to code patients’ responses based 
upon the predetermined themes in the interview guide. Member check-
ing (whereby participants provide feedback on the preliminary analysis) 
was not performed as we considered this to be too time-consuming for 
the patients. The main limitation of this study concerns incomplete data 
collection in the way that not all predetermined themes in the interview 
guide were discussed with all patients. As the flow of the dialogue was 
mainly set by the patients, the (main) interviewer did not strictly follow 
the interview guide over time, probably due to limited interviewing expe-
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rience. The fact that predetermined themes in the interview guide were 
not discussed with all patients was discovered during data analysis as the 
interviews were analysed at the end, rather than in an iterative process. 
As gender mediates the production and analysis of qualitative data,142 an-
other limitation might be that female breast cancer patients in the pre-
sent study were interviewed by a male interviewer. However, only one 
patient specifically requested to be interviewed by a female researcher. 
Furthermore, transcribed text showed that patients spoke freely about 
their preferences for follow-up. Therefore, we do not believe that using a 
male interviewer seriously affected patients’ responses concerning their 
preferences for follow-up.
In summary, >50% of patients were open to the possibility of primary 
care-based follow-up. Patients’ confidence with this follow-up model may 
increase by using survivorship care plans to facilitate communication 
across the primary/secondary interface and with patients. Training GPs 
to improve their oncology knowledge/skills might also serve to improve 
patients’ confidence.
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Figure 1. Flow diagram of the identification and inclusion of patients with early-
stage breast cancer.
Breast cancer in history and registered with a 
participating GP at the start of study (n = 167)
Not able to participate in the study according to the GP and 
excluded (n = 18)
Ş Not registered with the GP any longer (n = 6)
Ş Dutch not first language (n = 1)
Ş Cognitive and psychological problems (n = 7)
Ş Too old (n = 1)
Ş Treatment in another country (n = 1)
Ş Undergoing investigations for possible distant metastasis 
(n=1)
Ş Still undergoing breast cancer treatment (n=1)
Able to participate in the study according to 
the GP (n=149)
Excluded (n=77):
Ş Did not respond (n=75)
Ş Gave informed consent but declined to participate (n=2)
Ş Excluded from the analysis (n=2):
Ş Distant metastasis during follow-up (n=1)
Ş Patients’ preferences for follow-up were not discussed (n=1)
Gave informed consent (n=72) and were 
interviewed








Table 1. Patients’ preferences for follow-up: predetermined themes
DISCUSSED,  N (%)
Follow-up frequency 68 (97.1)
Follow-up duration 64 (91.4)
Care provider continuitya 61 (87.1)
Care provider: first choice 56 (80.0)
GP-led follow-up 68 (97.1)
Care provider continuity: GP versus specialistsa 38 (54.3)
aThese themes emerged from the pilot-interviews (n=10) and were added to the 
interview guide after these interviews
Table 2. Characteristics of the patients included in the analysis
N=70
Age at diagnosis, median (range), years 55.2 (27.4-83.9)











Systemic treatment, n (%)
None 12 (17.1)
Chemotherapy 35 (50.0)
Endocrine therapy 16 (22.9)
Chemotherapy + endocrine therapy 7 (10.0)
Recurrent breast cancer during follow-up, n (%)
Locoregional 3 (4.3)
Contralateral 2 (2.9)
Age at time of interview, median (range), years 62.6 (34.5-88.4)
Time since diagnosis, median (range), years 7.0 (1.0-23.1)
aT stage: type (in situ or invasive) and size of the tumour 
bN stage: absence or presence of the disease into the regional lymph nodes 
cIncluding patients treated with lumpectomy, with and without radiation therapy 
dIncluding patients treated with mastectomy, with and without radiation therapy.
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Table 3. Patients’ preferences for follow-up: frequency and duration
N (%)
Frequency (n=68)
< Every year 2 (2.9)
Every year 31 (45.6)
Twice a year 10 (14.7)
>Twice a year 6 (8.8)
Not more/less often than at present 6 (8.8)
Decreasing frequency over time* 10 (14.7)
Other 3 (4.4)
Duration (n=64)
< 5 years 1 (1.6)
5 years 8 (12.5)
7 years 2 (3.1)
10 years 16 (23.5)
>10 years 20 (31.3)
Lifelong 11 (17.2)
At least 5 years 3 (4.7)
Longer than at present 2 (3.1)
Duration recommended by the specialist 2 (3.1)
No preference 2 (3.1)
Other 8 (12.5)
*Of all patients (n=68), 27 would (also) like a schedule with a decreasing 
frequency over time
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There is a GP-patient relationship of trust
Patient receives more personal attention in general practice than in the hospital
General practice is nearby
General practice is easily accessible
Provided that there is good communication between the GP and specialists
Provided that the GP has sufficient knowledge about follow-up
No acceptance 28 (41.2)
GP has a broad medical knowledge
GP is not specialised/educated in follow-up
GP has insufficient experience/knowledge regarding follow-up
GP has too little time available/high workload for providing follow-up 
GP is not motivated to provide follow-up
Patient has less confidence in GP/more confidence in specialists
Patient feels confident/is satisfied with present hospital follow-up
GP missed breast cancer diagnosis
GP has to refer patients to the hospital
GP was not involved during the active treatment phase
Mammography has to be performed in the hospital
Effective links within the hospital
Neutral 1 (1.5)
CHAPTER 5 Chapter 5 Patients' preferences for post-treatment breast 
cancer follow-up in primary care versus secondary care: a qualitative study
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